RIZZELLO, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 663
EU - Europa 542
AS - Asia 87
AF - Africa 39
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.334
Nazione #
US - Stati Uniti d'America 659
IT - Italia 198
GB - Regno Unito 84
SE - Svezia 72
DE - Germania 67
CN - Cina 41
IE - Irlanda 34
IN - India 24
CI - Costa d'Avorio 18
BG - Bulgaria 15
TG - Togo 13
FR - Francia 12
FI - Finlandia 8
JO - Giordania 8
UA - Ucraina 8
PH - Filippine 7
CH - Svizzera 6
EE - Estonia 6
NL - Olanda 6
RU - Federazione Russa 5
ZA - Sudafrica 5
AT - Austria 4
CA - Canada 4
CZ - Repubblica Ceca 4
ES - Italia 4
BE - Belgio 3
NG - Nigeria 3
TR - Turchia 3
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
GR - Grecia 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
NO - Norvegia 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 1.334
Città #
Chandler 122
Southend 73
Bologna 63
Fairfield 63
Ashburn 62
Dublin 34
Woodbridge 31
Wilmington 27
Seattle 25
Houston 24
Princeton 24
Cambridge 21
Abidjan 18
Ann Arbor 16
New York 16
Sofia 15
Fabriano 14
Turin 14
Bremen 13
Lomé 13
Milan 13
Redmond 13
Amman 8
Beijing 8
Helsinki 8
Nanjing 8
Berlin 7
Florence 7
Bern 6
Dearborn 6
Padova 6
Westminster 6
Amsterdam 5
Nanchang 5
Redwood City 5
Riola 5
San Diego 5
Anoia Superiore 4
Falls Church 4
Hyderabad 4
Shenyang 4
Vienna 4
York 4
Abeokuta 3
Boydton 3
Brussels 3
Changsha 3
Des Moines 3
Javea 3
Munich 3
Pianoro 3
Saint Petersburg 3
Stilo 3
Ankara 2
Belgrade 2
Brno 2
Brookline 2
Cagliari 2
Hockenheim 2
Kiev 2
Kilburn 2
Leawood 2
Los Angeles 2
Manchester 2
Medford 2
Paris 2
Pisa 2
Poggio Renatico 2
Pune 2
Rochester 2
San Francisco 2
Toronto 2
Treviso 2
Victoria 2
Washington 2
Ahmedabad 1
Asahi 1
Azzano Decimo 1
Bari 1
Boardman 1
Brooklyn 1
Buffalo 1
Busseto 1
Bühl 1
Chengdu 1
Edinburgh 1
Esslingen am Neckar 1
Eugene 1
Frankfurt am Main 1
Fuzhou 1
Gazipur 1
Groningen 1
Guangzhou 1
Hebei 1
Hefei 1
Holt 1
Jiaxing 1
Jinan 1
Lamezia Terme 1
Latina 1
Totale 932
Nome #
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma 126
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma 116
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 115
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 109
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents 108
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 106
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia 103
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 99
null 98
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma 96
Emerging and current treatment combinations for transplant-ineligible multiple myeloma patients 61
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 51
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients 46
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 41
null 39
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma 29
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 21
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 21
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight 13
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients 7
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features 4
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 2
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 1
Totale 1.412
Categoria #
all - tutte 4.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.179


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 6 4
2019/2020200 25 5 0 8 25 24 28 28 23 12 18 4
2020/2021103 21 4 6 3 2 7 2 13 15 6 10 14
2021/2022301 7 13 15 37 14 12 12 25 16 46 56 48
2022/2023498 40 53 19 81 43 41 17 19 83 18 48 36
2023/2024251 17 29 15 19 18 53 9 55 6 17 13 0
Totale 1.412